Topical formulations often suffer from low skin penetration and rapid degradation of active compounds. Enhancing transdermal delivery through stable vesicle structures ensures effective therapeutic concentrations reach target skin layers.

Standard lipid mixtures often suffer from phase separation or crystallization over time. Stabilizing the alpha-gel structure prevents ingredient precipitation and maintains consistent texture for skin applications.